Breast-cancer cells have low to nonexistent levels of a protein that National Jewish researchers at have found inhibits cell proliferation.
The 2005 New Year will bring added incentive for Colorado residents to kick the tobacco habit -- the rising cost of tobacco. On January 1, 2005, the price of a pack of cigarettes will rise 64 cents. But the Colorado Quitline, a tobacco-cessation counseling service, will remain free.
Lynn M. Taussig, M.D., today announced his intention to retire in January 2006.
The National Jewish tobacco cessation program now offers free and confidential help kicking the tobacco habit in four states.
About one quarter of children in a long-term study of mild to moderate asthma suffered a significant loss of lung function over the course of four to six years.
About one quarter of children in a long-term study of mild to moderate asthma suffered a significant loss of lung function over the course of four to six years.
For the seventh consecutive year, National Jewish has been named the top respiratory hospital in the nation.
Researchers at National Jewish have identified a protein that inhibits the formation of new blood vessels. The findings suggest that fibulin-5 may one day be an effective cancer therapy.
Eighty years after adjuvants were first used to boost the effectiveness of vaccines, National Jewish researchers have finally begun to understand how they work.
National Jewish has been accredited by the Partnership for Human Research Protection (PHRP), a new program that seeks to protect the safety and rights of participants in clinical trials and research programs.